Naratuximab, CAS 1622327-39-2

Product Description: Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) is a humanized monoclonal antibody that binds CD37 (TSPAN26). Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Stuart W Hicks, et al. The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models. Neoplasia. 2017 Sep;19(9):661-671.

CAS Number: 1622327-39-2

Molecular Weight: N/A

Compound Purity: 99.0

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: ADC Antibody

• Artikelnummer: MEXHY-P99374-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99374-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated